<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1007395.ref023">
 <label>23</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Nathwani</surname>
   <given-names>AC</given-names>
  </name>, 
  <name>
   <surname>Reiss</surname>
   <given-names>UM</given-names>
  </name>, 
  <name>
   <surname>Tuddenham</surname>
   <given-names>EGD</given-names>
  </name>, 
  <name>
   <surname>Rosales</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Chowdary</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>McIntosh</surname>
   <given-names>J</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Long-term safety and efficacy of factor IX gene therapy in hemophilia B</article-title>. 
  <source>N Engl J Med</source>. 
  <year>2014</year>;
  <volume>371</volume>: 
  <fpage>1994</fpage>â€“
  <lpage>2004</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa1407309" xmlns:xlink="http://www.w3.org/1999/xlink">10.1056/NEJMoa1407309</ext-link>
  <?supplied-pmid 25409372?>
  <pub-id pub-id-type="pmid">25409372</pub-id>
 </mixed-citation>
</ref>
